deuterated glucose
Small moleculeexperimentalImaging agent
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2007 (NCT00548444)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Glucose transporterBINDING AGENT
SLC2A1 binding agent
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- deuterated glucose
- deuterated glucose
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04775121 | N/A | May 13, 2019 | Institut Gustave Roussy |
| NCT00548444 | Phase 1 | Oct 1, 2007 | University of London, University of Oxford, Wellcome Trust |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Institut Gustave Roussy | Academic/Hospital | 1 | 1 | 1 | 2019 |
| University of London | Academic/Hospital | 1 | 0 | 1 | 2007 |
| University of Oxford | Academic/Hospital | 1 | 1 | 1 | 2007 |
| Wellcome Trust | Academic/Hospital | 1 | 0 | 1 | 2007 |
4 organizations
Page 1 / 1